Alkermes Plc Stock Net Asset

ALKS Stock

USD 24.65 0.39 1.61%

Alkermes Plc fundamentals help investors to digest information that contributes to Alkermes Plc's financial success or failures. It also enables traders to predict the movement of Alkermes Stock. The fundamental analysis module provides a way to measure Alkermes Plc's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Alkermes Plc stock.

Short Long Term Debt Total Total Assets

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Alkermes Plc Company Net Asset Analysis

Alkermes Plc's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.

Net Asset

Current Market Value

-

Current Liabilities

More About Net Asset | All Equity Analysis

Current Alkermes Plc Net Asset

2.14 B

Most of Alkermes Plc's fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Alkermes Plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Alkermes Net Asset Driver Correlations

Understanding the fundamental principles of building solid financial models for Alkermes Plc is extremely important. It helps to project a fair market value of Alkermes Stock properly, considering its historical fundamentals such as Net Asset. Since Alkermes Plc's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Alkermes Plc's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Alkermes Plc's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Total Current Assets	Short Term Debt	Net Receivables	Short Term Investments	Common Stock	Current Deferred Revenue	Long Term Debt	Property Plant Equipment	Treasury Stock	Net Tangible Assets	Good Will	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Long Term Investments	Intangible Assets	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.92	-0.28	-0.74	0.79	0.88	0.88	-0.06	0.82	0.66	0.89	-0.33	0.11	0.78	-0.64	0.78	-0.35	-0.79	0.7	-0.65	0.2	-0.7	-0.71	-0.27	0.47	0.49
Total Stockholder Equity	0.92		-0.07	-0.49	0.67	0.63	0.74	0.05	0.6	0.72	0.85	-0.58	0.17	0.67	-0.43	0.72	-0.19	-0.71	0.5	-0.57	0.37	-0.46	-0.65	-0.05	0.2	0.22
Net Debt	-0.28	-0.07		0.59	-0.64	-0.48	-0.68	0.28	-0.69	-0.32	-0.06	-0.07	0.73	-0.01	0.74	-0.62	0.61	0.61	-0.75	0.54	0.18	0.8	0.62	0.32	-0.74	-0.74
Retained Earnings	-0.74	-0.49	0.59		-0.77	-0.89	-0.85	0.3	-0.94	-0.51	-0.71	-0.2	0.33	-0.7	0.94	-0.8	0.25	0.81	-0.9	0.73	-0.02	0.94	0.78	0.53	-0.63	-0.57
Accounts Payable	0.79	0.67	-0.64	-0.77		0.78	0.89	-0.29	0.88	0.55	0.62	-0.24	-0.33	0.54	-0.82	0.83	-0.56	-0.88	0.81	-0.72	0.06	-0.86	-0.82	-0.11	0.55	0.62
Total Liab	0.88	0.63	-0.48	-0.89	0.78		0.86	-0.17	0.92	0.45	0.75	0.04	0.0	0.76	-0.76	0.7	-0.47	-0.72	0.81	-0.61	-0.05	-0.85	-0.63	-0.47	0.69	0.71
Total Current Assets	0.88	0.74	-0.68	-0.85	0.89	0.86		-0.23	0.92	0.72	0.7	-0.18	-0.32	0.57	-0.86	0.93	-0.48	-0.89	0.89	-0.75	0.18	-0.91	-0.89	-0.39	0.66	0.68
Short Term Debt	-0.06	0.05	0.28	0.3	-0.29	-0.17	-0.23		-0.25	-0.13	-0.02	-0.25	0.27	-0.04	0.34	-0.23	0.1	0.14	-0.17	-0.24	0.04	0.32	0.43	0.14	-0.22	-0.2
Net Receivables	0.82	0.6	-0.69	-0.94	0.88	0.92	0.92	-0.25		0.51	0.69	-0.02	-0.31	0.65	-0.92	0.84	-0.47	-0.87	0.91	-0.75	-0.04	-0.96	-0.8	-0.4	0.71	0.69
Short Term Investments	0.66	0.72	-0.32	-0.51	0.55	0.45	0.72	-0.13	0.51		0.64	-0.22	-0.28	0.46	-0.56	0.81	-0.02	-0.69	0.61	-0.58	0.26	-0.53	-0.81	-0.19	0.31	0.15
Common Stock	0.89	0.85	-0.06	-0.71	0.62	0.75	0.7	-0.02	0.69	0.64		-0.24	0.17	0.93	-0.56	0.74	0.05	-0.69	0.67	-0.6	0.28	-0.57	-0.63	-0.17	0.33	0.15
Current Deferred Revenue	-0.33	-0.58	-0.07	-0.2	-0.24	0.04	-0.18	-0.25	-0.02	-0.22	-0.24		-0.09	0.0	-0.15	-0.21	0.24	0.32	0.03	0.17	-0.28	-0.08	0.12	-0.31	0.06	0.02
Long Term Debt	0.11	0.17	0.73	0.33	-0.33	0.0	-0.32	0.27	-0.31	-0.28	0.17	-0.09		0.27	0.58	-0.46	0.15	0.49	-0.45	0.44	-0.04	0.5	0.5	0.15	-0.26	-0.22
Property Plant Equipment	0.78	0.67	-0.01	-0.7	0.54	0.76	0.57	-0.04	0.65	0.46	0.93	0.0	0.27		-0.51	0.57	0.07	-0.54	0.62	-0.46	0.05	-0.52	-0.46	-0.11	0.38	0.14
Treasury Stock	-0.64	-0.43	0.74	0.94	-0.82	-0.76	-0.86	0.34	-0.92	-0.56	-0.56	-0.15	0.58	-0.51		-0.86	0.31	0.87	-0.91	0.79	-0.03	0.97	0.87	0.43	-0.61	-0.56
Net Tangible Assets	0.78	0.72	-0.62	-0.8	0.83	0.7	0.93	-0.23	0.84	0.81	0.74	-0.21	-0.46	0.57	-0.86		-0.2	-0.9	0.9	-0.79	0.32	-0.85	-0.95	-0.26	0.53	0.41
Good Will	-0.35	-0.19	0.61	0.25	-0.56	-0.47	-0.48	0.1	-0.47	-0.02	0.05	0.24	0.15	0.07	0.31	-0.2		0.38	-0.34	0.24	0.39	0.48	0.21	0.21	-0.62	-0.88
Long Term Debt Total	-0.79	-0.71	0.61	0.81	-0.88	-0.72	-0.89	0.14	-0.87	-0.69	-0.69	0.32	0.49	-0.54	0.87	-0.9	0.38		-0.84	0.85	-0.15	0.87	0.86	0.26	-0.52	-0.49
Capital Surpluse	0.7	0.5	-0.75	-0.9	0.81	0.81	0.89	-0.17	0.91	0.61	0.67	0.03	-0.45	0.62	-0.91	0.9	-0.34	-0.84		-0.8	0.03	-0.94	-0.81	-0.39	0.78	0.61
Deferred Long Term Liab	-0.65	-0.57	0.54	0.73	-0.72	-0.61	-0.75	-0.24	-0.75	-0.58	-0.6	0.17	0.44	-0.46	0.79	-0.79	0.24	0.85	-0.8		-0.16	0.76	0.7	0.26	-0.42	-0.38
Long Term Investments	0.2	0.37	0.18	-0.02	0.06	-0.05	0.18	0.04	-0.04	0.26	0.28	-0.28	-0.04	0.05	-0.03	0.32	0.39	-0.15	0.03	-0.16		0.03	-0.27	0.04	-0.38	-0.26
Intangible Assets	-0.7	-0.46	0.8	0.94	-0.86	-0.85	-0.91	0.32	-0.96	-0.53	-0.57	-0.08	0.5	-0.52	0.97	-0.85	0.48	0.87	-0.94	0.76	0.03		0.83	0.49	-0.75	-0.73
Short Long Term Debt	-0.71	-0.65	0.62	0.78	-0.82	-0.63	-0.89	0.43	-0.8	-0.81	-0.63	0.12	0.5	-0.46	0.87	-0.95	0.21	0.86	-0.81	0.7	-0.27	0.83		0.28	-0.44	-0.4
Net Invested Capital	-0.27	-0.05	0.32	0.53	-0.11	-0.47	-0.39	0.14	-0.4	-0.19	-0.17	-0.31	0.15	-0.11	0.43	-0.26	0.21	0.26	-0.39	0.26	0.04	0.49	0.28		-0.44	-0.54
Net Working Capital	0.47	0.2	-0.74	-0.63	0.55	0.69	0.66	-0.22	0.71	0.31	0.33	0.06	-0.26	0.38	-0.61	0.53	-0.62	-0.52	0.78	-0.42	-0.38	-0.75	-0.44	-0.44		0.79
Capital Stock	0.49	0.22	-0.74	-0.57	0.62	0.71	0.68	-0.2	0.69	0.15	0.15	0.02	-0.22	0.14	-0.56	0.41	-0.88	-0.49	0.61	-0.38	-0.26	-0.73	-0.4	-0.54	0.79

Click cells to compare fundamentals

Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.

Competition

Predict Alkermes Plc

Alkermes Total Assets

Total Assets

2.24 Billion

At this time, Alkermes Plc's Total Assets are comparatively stable compared to the past year.

Based on the recorded statements, Alkermes Plc has a Net Asset of 2.14 B. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The net asset for all United States stocks is notably lower than that of the firm.

Alkermes Net Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Alkermes Plc's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Alkermes Plc could also be used in its relative valuation, which is a method of valuing Alkermes Plc by comparing valuation metrics of similar companies.

Alkermes Plc is currently under evaluation in net asset category among related companies.

Alkermes Plc ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Alkermes Plc's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Alkermes Plc's managers, analysts, and investors.

Environment Score

Governance Score

Social Score

Alkermes Plc Institutional Holders

Institutional Holdings refers to the ownership stake in Alkermes Plc that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Alkermes Plc's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Alkermes Plc's value.

		Shares
Primecap Management Company	2023-12-31	3.6 M
Bank Of New York Mellon Corp	2023-12-31	3.3 M
Goldman Sachs Group Inc	2023-12-31	2.8 M
Morgan Stanley - Brokerage Accounts	2023-12-31	2.5 M
Dimensional Fund Advisors, Inc.	2023-12-31	2.4 M
Charles Schwab Investment Management Inc	2023-12-31	2.1 M
Artisan Partners Limited Partnership	2023-12-31	2.1 M
Norges Bank	2023-12-31	2 M
Nuveen Asset Management, Llc	2023-12-31	2 M
Blackrock Inc	2023-12-31	30 M
Vanguard Group Inc	2023-12-31	21 M

Alkermes Fundamentals

	Return On Equity	0.46
	Return On Asset	0.13
	Profit Margin	0.21 %
	Operating Margin	0.14 %
	Current Valuation	3.62 B
	Shares Outstanding	169.18 M
	Shares Owned By Insiders	1.24 %
	Shares Owned By Institutions	98.76 %
	Number Of Shares Shorted	14.34 M
	Price To Earning	(38.45) X
	Price To Book	3.39 X
	Price To Sales	2.45 X
	Revenue	1.66 B
	Gross Profit	893.69 M
	EBITDA	486.73 M
	Net Income	519.16 M
	Cash And Equivalents	580.97 M
	Cash Per Share	3.54 X
	Total Debt	290.73 M
	Debt To Equity	0.38 %
	Current Ratio	2.38 X
	Book Value Per Share	7.20 X
	Cash Flow From Operations	401.35 M
	Short Ratio	6.93 X
	Earnings Per Share	3.06 X
	Price To Earnings To Growth	(1,057) X
	Target Price	35.55
	Number Of Employees	2.1 K
	Beta	0.55
	Market Capitalization	4.1 B
	Total Asset	2.14 B
	Retained Earnings	(1.34 B)
	Working Capital	965.29 M
	Current Asset	754.96 M
	Current Liabilities	236.21 M
	Net Asset	2.14 B

About Alkermes Plc Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Alkermes Plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alkermes Plc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alkermes Plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Pair Trading with Alkermes Plc

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Alkermes Plc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alkermes Plc will appreciate offsetting losses from the drop in the long position's value.

Moving against Alkermes Stock

0.78	ACB	Aurora Cannabis Trending	Pair Corr
0.7	CGC	Canopy Growth Corp Trending	Pair Corr
0.68	ELYM	Eliem Therapeutics	Pair Corr
0.54	XFOR	X4 Pharmaceuticals Earnings Call Next Week	Pair Corr
0.51	NRSNW	NeuroSense Therapeutics	Pair Corr

The ability to find closely correlated positions to Alkermes Plc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Alkermes Plc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Alkermes Plc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Alkermes Plc to buy it.

The correlation of Alkermes Plc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Alkermes Plc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Alkermes Plc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Alkermes Plc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Alkermes Plc is a strong investment it is important to analyze Alkermes Plc's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Alkermes Plc's future performance. For an informed investment choice regarding Alkermes Stock, refer to the following important reports:

How To Invest In Alkermes

Details

Is Alkermes Stock a good investment?

Details

What is Alkermes Plc's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Alkermes Plc Piotroski F Score and Alkermes Plc Altman Z Score analysis.

For more information on how to buy Alkermes Stock please use our How to Invest in Alkermes Plc guide.

You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Complementary Tools for Alkermes Stock analysis

When running Alkermes Plc's price analysis, check to measure Alkermes Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alkermes Plc is operating at the current time. Most of Alkermes Plc's value examination focuses on studying past and present price action to predict the probability of Alkermes Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alkermes Plc's price. Additionally, you may evaluate how the addition of Alkermes Plc to your portfolios can decrease your overall portfolio volatility.

	Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
	Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios
	Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
	Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios
	Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules
	Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk
	Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
	ETFs Find actively traded Exchange Traded Funds (ETF) from around the world
	Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format
	Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences
	Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
	Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account

Is Alkermes Plc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alkermes Plc. If investors know Alkermes will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alkermes Plc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

3.06

Revenue Per Share

10.007

Quarterly Revenue Growth

0.239

Return On Assets

0.1281

Return On Equity

0.4622

The market value of Alkermes Plc is measured differently than its book value, which is the value of Alkermes that is recorded on the company's balance sheet. Investors also form their own opinion of Alkermes Plc's value that differs from its market value or its book value, called intrinsic value, which is Alkermes Plc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alkermes Plc's market value can be influenced by many factors that don't directly affect Alkermes Plc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Alkermes Plc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alkermes Plc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alkermes Plc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Alkermes Plc Stock Net Asset

Alkermes Plc Company Net Asset Analysis

Net Asset

Current Market Value

-

Current Liabilities

Current Alkermes Plc Net Asset

Alkermes Net Asset Driver Correlations

Alkermes Total Assets

Total Assets

2.24 Billion

Alkermes Net Asset Peer Comparison

Alkermes Plc ESG Sustainability

Alkermes Plc Institutional Holders

Alkermes Fundamentals

About Alkermes Plc Fundamental Analysis

Pair Trading with Alkermes Plc

Moving against Alkermes Stock

Complementary Tools for Alkermes Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY